| Entry date | September 24, 2002 12:00 +1GMT
| | Last update | July 14, 2019 22:38 +1GMT
|
| Allergome Code | 45
|
| Name | Api m 1 
|
| Previous Names | Api m I
|
| Common Names | a45, CCD-bearing Protein (XF), i208, k203, Phospholipase A2, PLA2
|
| Biological Function | Phospholipases
|
Isoforms, Variants,
Epitopes | Api m 1.0101
|
Hybrids, Polymers &
Shuffleds | Api m A1-A2, Api m A1-A2-A3
|
Links to Molecule
Sequences | Api m 1 - B7UUK1 - UNIPROT, Api m 1 - I1VC86 - UNIPROT, Api m 1.0101 - P00630 - UNIPROT
|
Links to Molecule
Structure | Api m 1 - 1POC - PDB
|
| Sources | |
Links to Source
Taxonomy | Api m - Discover Life, Api m - 154396 - ITIS, Api m - 7460 - NCBI, Api m - 7460 - UniProt, Api m - Wikipedia
|
| Links to Source Images | Apis mellifera on Google images | | Tissues | Venom
|
| Routes of Exposure | Sting
|
Epidemiology from
Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Austria | IgE | 7 | 100.000 | 20100514, Mittermann I
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 2.325 | 20101214, Gadisseur R
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 5.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 10.810 | 20090826, Ebo DG
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 14.140 | 20110223, De Knop KJ
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 1.000 | 20111214, Zheng YW
| | 5.1.1 - Source Exposed (Symptoms) | 2014 | France | IgE | 327 | 34.600 | 20140427, Lambert C
| | 1.10 - Any allergy symptom, Diagnosed | 2013 | Germany | IgE | 8 | 0.000 | 20131202, Cifuentes L
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2010 | Germany | IgE | 59 | 6.780 | 20100819, Hofmann SC
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2010 | Germany | IgE | 34 | 79.410 | 20100819, Hofmann SC
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Germany | IgE | 144 | 72.200 | 20140120, Kohler J
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Germany | IgE | 20 | 70.000 | 20100326, Blank S
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Germany | IgE | 13 | 69.200 | 2002, Binder M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Slovenia | IgE | 16 | 93.750 | 20100514, Mittermann I
| | 5.6.1 - Source Exposed (IgE) | 2011 | Slovenia | IgE | 184 | 91.840 | 20110412, Korosec P
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.10 - Any allergy symptom, Diagnosed | 2011 | Spain | IgE | 1,018 | 14.150 | 20111011, Vidal C
| | ... complete "Epidemiology from Literature" listing -> |
| | References | Biochemistry / Structure / Function
2014:
20140831, Matysiak J
- 20140331, Lollier V
- 20140310, Van Vaerenbergh M
2013:
20131104, Chan QW
- 20130731, DallAntonia F
- 20130626, Ferreira Resende V
- 20130128, Van Vaerenbergh M
2012:
20120720, Santiago HC
2011:
20111122, Seppala U
- 20110818, Sin BA
- 20110302, Dos Santos LD
- 20110221, Nishikawa H
2010:
20101221, Blank S
- 20101129, Lollier V
- 20100614, Dos Santos LD
- 20100514, Mittermann I
- 20100208, Rouvinen J
2009:
20090714, Tanasa RI
2008:
20081013, Francese S
- 20080801, Peiren N
... complete Reference listing ->
Molecular Biology
2010:
20101221, Blank S
- 20100514, Mittermann I
2007:
20070115, Crameri R
2005:
20051007, Karamloo F
- 20050210, Kussebi F
2004:
20041015, Jilek S
- 20041002, Buhot C
2002:
20021025, Moreira LA
2001:
2001, Jilek S
1998:
1998, Wymann D
1995:
1995a, Dudler T
1994:
1994, Dudler T
1992:
1992, Dudler T
1989:
1989, Kuchler K
Immunochemistry / Allergenicity
2014:
20140415, Celesnik SN
- 20140210, Aberer W
- 20140120, Kohler J
2013:
20130927, Holzweber F
- 20130420, Palazzo P
2012:
20121015, Varga EM
2011:
20110818, Sin BA
- 20110623, Sturm GJ
- 20110221, Nishikawa H
2010:
20101221, Blank S
- 20101214, Braren I
- 20100706, Hino S
- 20100514, Mittermann I
2009:
20090714, Tanasa RI
2007:
20070330, Braren I
2005:
20051007, Karamloo F
- 20050830, Li JH
- 20050210, Kussebi F
2004:
20041002, Buhot C
- 20040312, Hemmer W
... complete Reference listing ->
Immune-mechanisms / Genetics
2013:
20130304, van de Veen W
2011:
20110818, Sin BA
2008:
20081110, Meiler F
- 20081010, Meiler F
- 20081009, Muller UR
2007:
20070115, Crameri R
2006:
20060324, Tarzi M
2005:
20051007, Karamloo F
- 20050824, Sanchez-Velasco P
- 20050822, Bellinghausen I
- 20050210, Kussebi F
2003:
2003, Fellrath JM
2002:
2002, Texier C
2000:
2000, Texier C
1999:
1999, Texier C
- 1999, Faith A
1998:
1998, Wymann D
- 1998, Muller U
- 1998, Akdis CA
1997:
1997a, Kammerer R
... complete Reference listing ->
Detection - Source Extracts, Food Products, Drug Preparations
2014:
20140120, Kohler J
2008:
20080801, Peiren N
Detection - Allergy Diagnostic and Immunotherapeutic Products
2014:
20140120, Kohler J
2011:
20110610, Blank S
1979:
1979, Patrizzi R
Detection - Body Biodistribution
2011:
20111122, Seppala U
2008:
20081013, Francese S
Epidemiology
2014:
20140625, Armentia A
- 20140427, Lambert C
- 20140120, Kohler J
2013:
20131017, Prosperi MC
- 20130420, Palazzo P
2012:
20120716, Sturm GJ
- 20120528, Patelis A
2011:
20111214, Zheng YW
- 20111011, Vidal C
2009:
20090826, Ebo DG
2002:
2002, Mari A
Diagnosis
2014:
20141122, Hochwallner H
- 20140915, Sanchez M
- 20140906, Galindo-Bonilla PA
- 20140804, Rafei-Shamsabadi D
- 20140804, Cifuentes L
- 20140609, Rentzos G
- 20140502, Nakonechna A
- 20140427, Lambert C
- 20140415, Celesnik SN
- 20140331, Rockmann H
- 20140324, Heaps A
- 20140211, Martinez-Aranguren R
- 20140210, Aberer W
- 20140120, Kohler J
2013:
20131224, Sturm GJ
- 20131209, Cabauatan CR
- 20131202, Cifuentes L
- 20131028, Lupinek C
- 20131017, Prosperi MC
- 20131016, Lao-Araya M
... complete Reference listing ->
Immunotherapy
2006:
20060324, Tarzi M
2003:
2003, Fellrath JM
1998:
1998, Muller U
1988:
1988, Litwin A
Experimental Model - Allergic Immune Response
2013:
20131129, Waeckerle-Men Y
- 20131106, Palm NW
2009:
20090714, Tanasa RI
- 20090402, Martinez-Gomez JM
2007:
20071213, Johansen P
- 20070601, Gomez JM
2006:
20060105, Johansen P
2005:
20051223, Jin C
- 20051116, Johansen P
- 20051007, Karamloo F
- 20050210, Kussebi F
2004:
20041002, Buhot C
2003:
20030721, Lemke H
2002:
2002, Von Garnier C
- 2002, Lange H
Experimental Model - Inhalant-induced Diseases
2005:
20050115, Nishioka K
2001:
2001, Yamatomo T
Experimental Model - Injection-induced Diseases
2008:
20081013, Francese S
2004:
20041015, Jilek S
2002:
2002, Guerin V
2001:
2001, Jilek S
2000:
2000, von Garnier C
- 2000, Astori M
1999:
1999, Okano M
1998:
1998, Seeger M
1997:
1997, Specht C
1995:
1995a, Dudler T
1993:
1993, Mori A
1990:
1990, Pesce AJ
1976:
1976b, Light WC
Review, Editorial, Report Citations, Other Resources
2014:
20141128, Commins SP
- 20141104, Akdis CA
- 20141016, van Rooyen C
- 20141011, Jutel M
- 20140926, Akdis M
- 20140922, Luengo O
- 20140919, Muller S
- 20140919, Hemmer W
- 20140731, Baird FJ
- 20140724, Palomares O
- 20140625, Mingomataj EC
- 20140617, Antolin-Amerigo D
- 20140610, Golden DB
- 20140606, Patural M
- 20140526, Marth K
- 20140328, Knisely AJ
- 20140311, Spillner E
- 20140217, Gupta K
- 20140204, Ebo DG
- 20140121, Steinke JW
... complete Reference listing -> |
|
Loading...
)
)
)
)
)
)
)
)
)
)
)
)
)